10 likes | 83 Views
Gender Differences in Physical/Sexual Abuse in Outpatients with SUDs: Correlates with Medical and Psychiatric Symptoms L. Islam 1 , A. Sepulveda 1 , A. Alvanzo 2 , L. Keyser-Marcus 1 , T. Reickman 3 , M. Stitzer 2 , and D. Svikis 1
E N D
Gender Differences in Physical/Sexual Abuse in Outpatients with SUDs: Correlates with Medical and Psychiatric Symptoms L. Islam1, A. Sepulveda1, A. Alvanzo2, L. Keyser-Marcus1, T. Reickman3, M. Stitzer2, and D. Svikis1 1Virginia Commonwealth University, Richmond, VA; 2Johns Hopkins School of Medicine, Baltimore, MD; 3Oregon Health and Science University, Portland, OR Demographics (N = 628) Introduction Statistical Summary • Unemployment is a chronic problem in drug dependent individuals.1,2,3 • Job Seekers’ Workshop (JSW) program was developed specifically for drug dependent individuals and has demonstrated efficacy across several well-designed studies1,2,3 • Through the NIDA CTN, the efficacy of JSW was studied in a much larger and more heterogeneous sample of drug dependent individuals. • Since rates of physical and sexual abuse in persons with Substance Use Disorders (SUD) vary greatly across studies, this study offers a large, relevant sample to examine. • Women reported higher rates of physical (60.9%) and sexual • (47.9%) abuse (lifetime) than men (24.7% and 12.5%, • respectively, both p<.001). • Men and women with physical abuse were more likely to • report recent depression (.008<p<.001); lifetime depression • (.002<p<.001) and trouble controlling violent behavior • (lifetime) (p<.001). • Men with physical abuse were more likely to report chronic • medical problems (73%) than men without abuse (51%) • (p<.001). • Chronic medical problem rates were comparable for women • with and without abuse. • Similar patterns were seen for men and women with and • without a sexual abuse history. Those with sexual abuse • reported higher rates of recent and lifetime depression and • trouble controlling violence (lifetime). • Rates of chronic medical problems were comparable for • all groups. Substance Use Disorders (N = 628) Purpose • To examine prevalence rates in a diverse sample of men and women with SUDs and their medical/psychiatric correlates with the goal of informing clinical practice. Method • Participants were recruited from 6 drug free, psychosocial • treatment (PT) and 5 methadone maintenance (MM) programs • (N = 628) participating in a NIDA Clinical Trials Network (CTN) • randomized clinical trial (RCT) of an employment intervention. • All subjects completed Addiction Severity Index (Lite) as part • of baseline. • Males and females with and without physical and sexual abuse • (lifetime) were compared on a variety of medical & psychiatric • measures with chi-square analyses. Discussion Reported Lifetime Abuse • Women with SUDs report physical and sexual abuse at rates • double those of men with SUDs. • History of physical and sexual abuse was associated with • increased rates of depression and trouble controlling violence in • both genders. • Men with physical abuse were more likely to present for • treatment with a chronic medical problem. • The constellation of problems suggests both men and women • with histories of abuse would benefit from psychiatric evaluation • and ancillary intervention services. Inclusion Criteria • Inclusion criteria: • - 18 years of age or older • - Met DSM-IV criteria for Substance Abuse/Dependence • (lifetime) • - Reported unemployment or < 20 hrs work in any week of • prior month • - Completed at least 30 days of treatment at baseline • assessment Chronic Medical Problems References 1Hall, SM, Loeb, P, Coyne, K, et al. (1981). Increasing employment in ex-heroin addicts I: Criminal justice sample. Behavior Therapy, 12, 443-452. 2Hall, SM, Loeb, P, LeVois, M, et al. (1981). Increasing employment in ex-heroin addicts II: Methadone maintenance sample. Behavior Therapy, 12, 453-460. 3Hall, SM, Loeb, P, and Norton, J. (1977). Improving vocational placement in drug treatment clients: A pilot study. Addictive Behaviors, 2, 227-234. Acknowledgements This research was supported by a grant from the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) (Mid-Atlantic Node).